Gemini Therapeutics is a precision medicine company focused on the development of new therapies through a deeper understanding of disease. We are sharply focused on dry AMD which is a disease comprised of numerous genetic variants. We also believe that more precisely targeted therapeutics could better address the cause of a patient’s disease.

We work to create a world where lumbar herniation doesn’t define lives. For two decades, we worked with world-renowned surgeons, scientists, clinical investigators, and medical advisors to develop the Barricaid solution for patients at high risk for reherniation.

Jun 02, 2022 · Join our team of 3,000+ purpose-driven people determined to define what’s next in total drug management. Our employees are dedicated to improving health outcomes, creating a better member experience and lowering the total cost of care.

Tizona continues to develop a pipeline of innovative first-in-class immunomodulatory therapeutics focusing on targets expressed on leukocytes and tumor cells. Blocking these targets has the potential to stimulate the immune system and limit tumor cell growth with the potential to broadly impact patients with cancer.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on creating novel precision medicines for the treatment of rare muscle disorders. Science. ... People living with rare muscle disorders don’t let the disease define them. At Edgewise, our goal is to develop innovative therapies for progressive muscle disorders, with ...

Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.

We define our priorities clearly, communicate them and take collective accountability to deliver results for all stakeholders. We commit to achieving or beating performance expectations, and we celebrate the success of our colleagues and stakeholders. We are resilient and determined to succeed together because patients are depending on us.

We strive for people to live longer, healthier lives. To make this vision a reality, we provide premium laboratory research services to biotechnology and pharmaceutical companies.

Mar 16, 2022 · "Joining the Digital Therapeutics Alliance is a huge opportunity for ieso to be at the forefront of digital therapeutic innovation and adoption in …

Mar 09, 2022 · Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. Founded by CRISPR inventors and ...